Publication
PD-1 Inhibitor (Sintilimab) Combined With Chemotherapy as Neoadjuvant Therapy in Advanced Ovarian Cancer: A Case Report.
Wang Zhenyan, Wang Yan
Clinical case reportsOct 1, 2026PMID 42801091doi:10.1002/ccr3.73598 PMC13615360Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260929-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
In a patient with advanced ovarian cancer showing limited response to paclitaxel-carboplatin, adding sintilimab was associated with R0 cytoreduction and sustained disease-free status during olaparib-bevacizumab maintenance. This case provides a rationale for further investigation of PD-1 blockade…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Ovarian Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.